Safety of Biologics Approved for the Treatment of Rheumatoid Arthritis and Other Autoimmune Diseases: A Disproportionality Analysis from the FDA Adverse Event Reporting System (FAERS)
Araujo, Ariane G. S., Borba, Helena H. L., Tonin, Fernanda S., Lenzi, Luana, Venson, Rafael, Pontarolo, Roberto, Wiens, AstridLanguage:
english
Journal:
BioDrugs
DOI:
10.1007/s40259-018-0285-2
Date:
June, 2018
File:
PDF, 597 KB
english, 2018